JPX · 4507.T
Shionogi & Co., Ltd.
¥3,012+¥23 (+0.77%)
Shionogi & Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.85% below the high.
Loading market information…
JPX · 4540.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Tsumura & Co.’s quoted price sits in the lower half of its reported 52-week range, 13.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tsumura & Co.’s forward annual dividend is ¥158 per share, paid semi-annual. The forward yield is 4.14% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Tsumura & Co.’s next earnings report is currently expected on Nov 9, 2026, with estimated earnings per share of ¥110. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tsumura & Co.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus on Kampo extract intermediates and granular Kampo preparations. Its operations are comprehensive, encompassing the full supply chain: from the careful acquisition, selection, processing, and warehousing of raw herbal materials and crude drug components for decoctions, to the manufacturing of powdered Kampo extracts and traditional Chinese medicines. Additionally, Tsumura & Co. is engaged in the sale of both pharmaceutical goods and food products.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| ¥44.32B-4.52% vs estimate |
| Q3 2025 | Feb 6, 2025 | ¥119+27.61% vs estimate | ¥47.7B-3.84% vs estimate |
|---|
| Q2 2025 | Nov 7, 2024 | ¥83-10.99% vs estimate | ¥45.38B-2.72% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥3,012+¥23 (+0.77%)
Shionogi & Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 19.85% below the high.
¥1,885-¥61 (-3.11%)
Sumitomo Pharma Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.69% below the high.
¥3,436+¥18 (+0.53%)
Nippon Shinyaku Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 47.37% below the high.
¥1,667-¥17 (-1.01%)
Sawai Group Holdings Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.9% below the high.
¥3,520+¥60 (+1.73%)
Towa Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 21.6% below the high.
¥3,805+¥90 (+2.42%)
Kissei Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.5% below the high.
¥3,830+¥30 (+0.79%)
Kaken Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 13.84% below the high.
¥1,323+¥19 (+1.46%)
Daito Pharmaceutical Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.02% below the high.
